Izon Science

Izon Science, founded in 2005, specializes in precise and scalable nanoparticle isolation, along with high-resolution particle characterization. The company caters to nanoparticle researchers in various disciplines, providing scalable extracellular vesicles (EVs) isolation solutions for diagnostics, therapeutics, and fundamental research. Izon's range of size exclusion chromatography-based qEV columns, associated instrumentation, and custom bioprocessing development services cater to diverse customers, accommodating a broad range of sample types and volumes. The company's Exoid, featuring Tunable Resistive Pulse Sensing (TRPS) technology, offers high-resolution insights into the physical characterization of EVs, lipid nanoparticles, and viruses, enabling researchers to measure particle size, concentration, and zeta potential on a particle-by-particle basis. With a global presence and offices in Christchurch (New Zealand – Headquarters), Lyon (France), Boston, and Texas (US), Izon Science has established a strong network across key locations. Izon Science's innovative technology and global reach position it as a key player in the Biotechnology and Manufacturing industries, offering valuable solutions to researchers and businesses in the nanoparticle research space. While specific details regarding the last investment and investors are not available, the company's innovative approach and international presence make it an intriguing prospect for potential venture capital investment.